![](https://webarchive.library.unt.edu/eot2008/20090117203457im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Nonprescription Drugs Advisory Committee
Purpose
The Committee shall review and evaluate available data concerning the safety and effectiveness of over-the-counter (nonprescription) human drug products, or any other FDA-regulated product, for use in the treatment of a broad spectrum of human symptoms and diseases and advise the Commissioner either on the promulgation of monographs establishing conditions under which these drugs are generally recognized as safe and effective and not misbranded or on the approval of new drug applications for such drugs. The Committee will serve as a forum for the exchange of views regarding the prescription and nonprescription status, including switches from one status to another, of these various drug products and combinations thereof. The Committee may also conduct peer review of agency sponsored intramural and extramural scientific biomedical programs in support of FDA's mission and regulatory responsibilities.
Meeting Information
- 2008 meetings
- Past Meetings:
Contact
LCDR Diem-Kieu Ngo, Pharm.D., BCPS, R.Ph., Designated Federal Official
Advisors and Consultants Staff
Center for Drug Evaluation and Research
Food and Drug Administration,
5630 Fishers Lane, HFD-21
Rockville, Maryland 20857
(301) 827-7001
Fax: (301) 827-6776
E-mail: Diem.Ngo@fda.hhs.gov
Committee Membership
The Committee shall consist of a core of 14 voting members, including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of internal medicine, family practice, clinical toxicology, clinical pharmacology, pharmacy, dentistry, and related specialties. The core of voting members may include one technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumer-oriented organizations or other interested persons. In addition to the voting members, the Committee may include one non-voting member who is identified with industry interests.
Committee Resources
- Committee Vacancies
- Committee Charter
- Roster (members)
- FDA Advisory Committee Information Line
1-800-741-8138
(301) 443-0572 (local number)
code: 3014512541
Please call the Information Line for up-to-date information on meetings.
Related Links
Back to Top
Back to Human Drug Advisory Committees
PDF requires the free
Adobe Acrobat Reader
Date created: September 2, 2008 |
![](https://webarchive.library.unt.edu/eot2008/20090117203457im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |